18th week of 2019 patent applcation highlights part 10 |
Patent application number | Title | Published |
20190125721 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME | 2019-05-02 |
20190125722 | MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF | 2019-05-02 |
20190125723 | HYCANTHONE DERIVATIVES AND PRIMAQUINE DERIVATIVES FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF DISORDERS ASSOCIATED TO GAMMAHERPESVIRUS | 2019-05-02 |
20190125724 | PREVENTION AND TREATMENT OF VIRAL INFECTIONS | 2019-05-02 |
20190125725 | PHARMACEUTICAL COMPOSITIONS COMPRISING BRIVARACETAM | 2019-05-02 |
20190125726 | AGENT FOR TREATING SYNUCLEINOPATHY | 2019-05-02 |
20190125727 | FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA | 2019-05-02 |
20190125728 | HETEROCYCLIC COMPOUND | 2019-05-02 |
20190125729 | NOVEL TRAPS IN THE TREATMENT OF MACULAR DEGENERATION | 2019-05-02 |
20190125730 | OXADIAZOLES AND THIADIAZOLES AS TGF-BETA INHIBITORS | 2019-05-02 |
20190125731 | ANTIFIBROTIC COMPOUNDS AND USES THEREOF | 2019-05-02 |
20190125732 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND A METHOD THEREOF | 2019-05-02 |
20190125733 | COMPOSITIONS COMPRISING SUBSTITUTED BENZOFUROQUINOLIZINE AND PSYCHOACTIVE DRUG | 2019-05-02 |
20190125734 | COMPOSITION FOR TREATING OR PREVENTING ATOPIC DERMATITIS | 2019-05-02 |
20190125735 | INHIBITION OF P38 MAPK FOR THE TREATMENT OF CANCER | 2019-05-02 |
20190125736 | USE OF 2-SUBSTITUTED INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES | 2019-05-02 |
20190125737 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | 2019-05-02 |
20190125738 | NEUROKININ ANTAGONISTS AND USES THEREOF | 2019-05-02 |
20190125739 | QUINOLINE DERIVATIVE FOR TREATING GASTRIC CANCER | 2019-05-02 |
20190125740 | 6-(6-MEMBERED HETEROARYL & ARYL)ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | 2019-05-02 |
20190125741 | 6-(5-MEMBERED HETEROARYL)ISOQUINOLIN-3-YL-(5-MEMBERED HETEROARYL) CARBOXAMIDES AND PREPARATION AND USE THEREOF | 2019-05-02 |
20190125742 | TREATMENT OF GLIOMAS USING ORGANONITRO COMPOUND COMBINATION THERAPY | 2019-05-02 |
20190125743 | COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH ACETYLCHOLINESTERASE INHIBITORS | 2019-05-02 |
20190125744 | LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS | 2019-05-02 |
20190125745 | TREATMENT AND DIAGNOSIS OF CANCER | 2019-05-02 |
20190125746 | NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS | 2019-05-02 |
20190125747 | FORMULATIONS OF A COMPOUND MODULATING KINASES | 2019-05-02 |
20190125748 | TREATMENT OF HIPPO PATHWAY MUTANT TUMORS AND METHODS OF IDENTIFYING SUBJECTS AS CANDIDATES FOR TREATMENT | 2019-05-02 |
20190125749 | POLYMORPHS OF ARRY-380, A SELECTIVE HER[[B]]2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONT[[l]]AINING THEM | 2019-05-02 |
20190125750 | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS | 2019-05-02 |
20190125751 | ANTICANCER COMBINATION THERAPY | 2019-05-02 |
20190125752 | Highly Active Anti-Neoplastic and Anti-Proliferative Agents | 2019-05-02 |
20190125753 | COMPOUNDS AND METHODS FOR INCREASING HEMATOPOIESIS | 2019-05-02 |
20190125754 | BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE | 2019-05-02 |
20190125755 | A COMPOSITION COMPOSED OF CEFTRIAXONE SODIUM AND SULBACTUM SODIUM | 2019-05-02 |
20190125756 | METHOD OF TREATING HYPERTENSION | 2019-05-02 |
20190125757 | METHOD FOR TREATING CANCER USING A SELENOUREA-COORDINATED GOLD(I)-CARBENE COMPLEX | 2019-05-02 |
20190125758 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | 2019-05-02 |
20190125759 | ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT | 2019-05-02 |
20190125760 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2019-05-02 |
20190125761 | Reduction of Side Effects from Aromatase Inhibitors Used for Treating Breast Cancer | 2019-05-02 |
20190125762 | INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CYCLODEXTRIN A HYDROPHOBIC DRUG, A CO-SOLVENT, AND A PRESERVATIVE | 2019-05-02 |
20190125763 | NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE | 2019-05-02 |
20190125764 | OXYSTEROLS AND METHODS OF USE THEREOF | 2019-05-02 |
20190125765 | COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER | 2019-05-02 |
20190125766 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION | 2019-05-02 |
20190125767 | 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USES THEREOF | 2019-05-02 |
20190125768 | TREATMENT OF RHEUMATOID ARTHRITIS | 2019-05-02 |
20190125769 | COMBINATIONAL THERAPIES FOR TREATMENT OF CANCER COMPRISING A BACTERIOCHLOROPHYLL DERIVATIVE | 2019-05-02 |
20190125770 | (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | 2019-05-02 |
20190125771 | LIVER SPECIFIC DELIVERY-BASED ANTIVIRAL PRODRUG NUCLEOSIDE CYCLOPHOSPHATE COMPOUND AND USES THEREOF | 2019-05-02 |
20190125772 | IMPROVED DRUG COMBINATIONS FOR DRUG-RESISTANT AND DRUG-SENSITIVE MULTIPLE MYELOMA | 2019-05-02 |
20190125773 | METHODS FOR CANCER THERAPY | 2019-05-02 |
20190125774 | ANTIMICROBIAL ADHESIVE FORMULATION AND FILM DRESSINGS HAVING AN ANTIMICROBIAL ADHESIVE | 2019-05-02 |
20190125775 | Methods and Compounds for Stimulating Read-Through of Premature Termination Codons | 2019-05-02 |
20190125776 | TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT | 2019-05-02 |
20190125777 | METHODS AND MATERIALS FOR REDUCING THE RISK OF INFECTIONS | 2019-05-02 |
20190125778 | HAPTEN-ENHANCED CHEMOIMMUNOTHERAPY BY ULTRA-MINIMUM INCISION PERSONALIZED INTRATUMORAL CHEMOIMMUNOTHERAPY | 2019-05-02 |
20190125779 | PHARMACEUTICAL COMPOSITIONS | 2019-05-02 |
20190125780 | METHOD FOR PREVENTING AND TREATING RENAL DISEASE | 2019-05-02 |
20190125781 | Compositions and Methods to Affect Skin Irritation | 2019-05-02 |
20190125782 | NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES | 2019-05-02 |
20190125783 | AGENT FOR USE FOR INFLAMMATORY CONDITIONS OF MUCOUS MEMBRANES | 2019-05-02 |
20190125784 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | 2019-05-02 |
20190125785 | HYPOTHERMAL INHALATION GAS COMPOSITION | 2019-05-02 |
20190125786 | NOBLE GAS MODULATION OF IL-12 | 2019-05-02 |
20190125787 | Pharmaceutical Preparation Containing Selenite or Selenite-Containing Compounds for Treating Cervical Dysplasia or Carcinomas | 2019-05-02 |
20190125788 | CALCIUM ELECTROPORATION DELIVERY APPARATUS AND METHOD | 2019-05-02 |
20190125789 | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF TRAUMA-INDUCED NEUROPATHOLOGY AND NEURODEGENERATION | 2019-05-02 |
20190125790 | USE OF HYPOCHLOROUS ACID AS A TOPICAL ANTIMICROBIAL | 2019-05-02 |
20190125791 | PREVENTIVE AND CURATIVE PEROXOMETALLATE BASED COMPOSITION, NOTABLY PHARMACEUTICAL COMPOSITION | 2019-05-02 |
20190125792 | PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF | 2019-05-02 |
20190125793 | COMPOSITION COMPRISING CINNAMALDEHYDE AND ZINC TO IMPROVE SWALLOWING | 2019-05-02 |
20190125794 | NOVEL OPTHALMIC STEM CELL TREATMENT AND METHOD | 2019-05-02 |
20190125795 | COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES | 2019-05-02 |
20190125796 | PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS | 2019-05-02 |
20190125797 | USE OF TRANS-SIGNALING APPROACH IN CHIMERIC ANTIGEN RECEPTORS | 2019-05-02 |
20190125798 | Chimeric antigen receptor (CAR) and T cell receptor (TCR) Modified T cells | 2019-05-02 |
20190125799 | METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS | 2019-05-02 |
20190125800 | TYPE 2 INNATE LYMPHOID CELLS AND METHODS OF ENRICHING AND GROWING | 2019-05-02 |
20190125801 | TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS | 2019-05-02 |
20190125802 | Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant | 2019-05-02 |
20190125803 | MESENCHYMAL STEM CELL AND USE THEREOF FOR TREATMENT OF MUSCLE INJURY AND MUSCLE-ASSOCIATED DISEASES | 2019-05-02 |
20190125804 | ANTI-CANCER USE OF GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS (HUCPVC) | 2019-05-02 |
20190125805 | AGENT FOR REGULATING COMPOSITION RATIO OF THE INTESTINAL MICROBIOTA, DRUG, FOOD, DRINK AND METHOD FOR REGULATING COMPOSITION RATIO OF THE INTESTINAL MICROBIOTA | 2019-05-02 |
20190125806 | Antimicrobial and Antiviral Agent, Antimicrobial and Antiviral Member, and Method for Producing Antimicrobial and Antiviral Agent | 2019-05-02 |
20190125807 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF OXALATE-RELATED DISORDERS | 2019-05-02 |
20190125808 | METHODS OF PREVENTING, TREATING AND DETECTING COLORECTAL CANCER USING BUTYRATE PRODUCING BACTERIA | 2019-05-02 |
20190125809 | COMPOSITIONS AND METHODS COMPRISING BACTERIA FOR IMPROVING BEHAVIOR IN NEURODEVELOPMENTAL DISORDERS | 2019-05-02 |
20190125810 | BACILLUS SUBTILIS CONTAINING COMPOSITION FOR TEATEMENT OF GASTROINTESTINAL IRREGULAIRTY | 2019-05-02 |
20190125811 | PROBIOTIC (BACILLUS SUBTILIS) SUPPLEMENTATION FOR IMPROVEMENT OF BODY COMPOSITION IN FEMALE ATHLETES | 2019-05-02 |
20190125812 | COMPOSITIONS AND METHODS COMPRISING BACTERIA FOR IMPROVING BEHAVIOR IN NEURODEVELOPMENTAL DISORDERS | 2019-05-02 |
20190125813 | POWDER FORMULATION HAVING A FUNCTION OF ENHANCING IMMUNITY AND METHOD FOR PREPARING THE SAME | 2019-05-02 |
20190125814 | EXTRACT OF ANDROGRAPHIS PANICULATA FOR COGNITIVE ENHANCEMENT | 2019-05-02 |
20190125815 | Topical Pharmaceutical Composition for Treating Multiple Wounds of Skin and the Preparation Methods Thereof | 2019-05-02 |
20190125816 | Herbo-mineral Formulation for prevention, treatment and management of Diabetes and method of preparation thereof | 2019-05-02 |
20190125817 | COMPOSITION COMPRISING TANNINS | 2019-05-02 |
20190125818 | Botanical Extracts and Compounds from Castanea Plants and Methods of Use | 2019-05-02 |
20190125819 | PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD COMPRISING OAT EXTRACT AVENANTHRAMIDE C OR DERIVATIVE THEREOF AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE | 2019-05-02 |
20190125820 | POWDER FOR REGULATING INTESTINAL FLORA AND PROTECTING GASTRIC MUCOSA, PREPARATION METHOD AND USE THEREOF | 2019-05-02 |